Information

Related Research Units

Infectious Diseases Research

Research Overview

Dr. Don Goldmann’s research interests fall under five overarching themes:

  1. Epidemiology and control of healthcare associated Infections in newborns and other hospitalized populations: My early career focused on elucidating risk factors for neonatal nosocomial infections, especially bloodstream infections. I was part of a team that developed and validated a physiological risk score for neonatal outcomes, SNAP. I continue to be involved in studying the epidemiology and prevention of neonatal infections, as well as healthcare associated infections in other patient populations (including patients in institutions in low-income countries).
  2. Antibiotic resistance and stewardship: I developed the first example of a standardized order set for antibiotic prescribing, demonstrating a major reduction in the inappropriate use of antibiotics for prophylaxis. In 1996, I published consensus guidance on preventing the emergence and spread of antibiotic resistance in JAMA – guidelines that remain among the core principles of antibiotic stewardship today. I led a CDC HICPAC taskforce that issued national recommendations for the appropriate use of Vancomycin and measures to control the emergence of Vancomycin Resistant Enterococci (VRE). I was the PI on the first NIAID-sponsored RCT of methods to reduce spread of Methicillin-Resistant S. aureus (MRSA) and VRE. I tested methods developed in the US in low-income settings, such as a NICU in Manila, demonstrating the challenges faced by these institutions in controlling the spread of resistance. I am core faculty on the national Vermont Oxford antibiotic stewardship MOOC and virtual learning community.
  3. Improvement/implementation science: Over the past two decades, I have increasingly turned my attention to quality improvement, implementation science, and comparative effectiveness research of quality improvement interventions. I am Chief Scientific Officer, Emeritus at the Institute for Healthcare Improvement. I am especially interested in the impact of policy and payment on health care outcomes, prevention of harm, overuse of tests and procedures, QI measurement, and the potential for technology to improve patient outcomes and population health.
  4. Program design and evaluation: It has become apparent that most ambitious demonstration projects to improve health outcomes fail. My colleague, Gareth Parry, and I have studied the reasons for these disappointing results and believe that a major reason is the use of fixed protocol designs that do not allow investigators to amend their approach based on conditions and context in intervention sites. Bayesian theory and improvement science provide a more flexible, dynamic approach to design and evaluation of large programs. We favor the embedding evaluators in action research project designs.
  5. Translational research: Although my research focuses on the “right end” of the translational pathway – translating research evidence into effective practice at-scale, it is important to understand the earlier translational steps in the pathway. Accordingly, I have been a contributor to two major pragmatic bench research efforts – a program to understand the pathogenesis of E. coli meningitis in neonates and develop approaches to protecting infants, and development of a candidate vaccine for Staphylococcal infection. This experience has kept me familiar with rapid advances in science so that I can insure that the work of implementers and improvers “speaks” to scientific progress.

Research Background

Don Goldmann is a graduate of Harvard Medical School. He completed an internship, residency, and fellowship at Massachusetts General Hospital. He served as an Epidemic Intelligence Service Officer of the Centers for Disease Control before returning to MGH for an Infectious Diseases Fellowship. He directed the Boston Children’s Hospital Microbiology Lab for nearly two decades and served as Hospital Epidemiologist and Medical Director of Quality Improvement. His teaching includes a General Education Course at Harvard College on the impact of infectious disease on history, society, the humanities, and social justice.

 

Education

Medical School

Harvard Medical School
1969 Boston MA

Internship

Internal Medicine Massachusetts General Hospital
1970 Boston MA

Residency

Massachusetts General Hospital
1971 Boston MA

Residency

Massachusetts General Hospital
1973 Boston MA

Fellowship

Infectious Diseases Massachusetts General Hospital
1975 Boston MA

Publications

  1. Preventing and Controlling Global Antimicrobial Resistance - Implementing a Whole-System Approach. N Engl J Med. 2024 Aug 22; 391(8):681-685. View Abstract
  2. Pediatric Tuberculosis Infection Care Facilitators and Barriers: A Qualitative Study. Pediatrics. 2024 Mar 01; 153(3). View Abstract
  3. Area-Based Sociodemographic Factors Associated with Latent Tuberculosis Infection in a Low-Prevalence Setting. Am J Trop Med Hyg. 2023 09 06; 109(3):595-599. View Abstract
  4. Racial and Ethnic Differences in Length of Stay for US Children Hospitalized for Acute Osteomyelitis. J Pediatr. 2023 08; 259:113424. View Abstract
  5. The CONFIDENT study protocol: a randomized controlled trial comparing two methods to increase long-term care worker confidence in the COVID-19 vaccines. BMC Public Health. 2023 02 23; 23(1):384. View Abstract
  6. Interferon Gamma Release Assay Results and Testing Trends Among Patients Younger Than 2 Years Old at Two US Health Centers. Pediatr Infect Dis J. 2023 03 01; 42(3):189-194. View Abstract
  7. Increasing Use Of Interferon Gamma Release Assays Among Children =2 Years of Age in a Setting With Low Tuberculosis Prevalence. Pediatr Infect Dis J. 2022 12 01; 41(12):e534-e537. View Abstract
  8. Multicenter Analysis of Attrition from the Pediatric Tuberculosis Infection Care Cascade in Boston. J Pediatr. 2023 02; 253:181-188.e5. View Abstract
  9. Characteristics of achieving clinically important weight loss in two paediatric weight management interventions. Pediatr Obes. 2021 09; 16(9):e12784. View Abstract
  10. Institutional quality and patient safety programs: An overview for the healthcare epidemiologist. Infect Control Hosp Epidemiol. 2021 01; 42(1):6-17. View Abstract
  11. A Collaborative Multicenter QI Initiative to Improve Antibiotic Stewardship in Newborns. Pediatrics. 2019 12; 144(6). View Abstract
  12. The impact of measurement changes on evaluating hospital performance: The case of catheter-associated urinary tract infections. Infect Control Hosp Epidemiol. 2019 11; 40(11):1269-1271. View Abstract
  13. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med. 2019 02 14; 380(7):638-650. View Abstract
  14. Association Between Value-Based Incentive Programs and Catheter-Associated Urinary Tract Infection Rates in the Critical Care Setting. JAMA. 2019 02 05; 321(5):509-511. View Abstract
  15. Effectiveness of a multistate quality improvement campaign in reducing risk of surgical site infections following hip and knee arthroplasty. BMJ Qual Saf. 2019 05; 28(5):374-381. View Abstract
  16. A framework for learning about improvement: embedded implementation and evaluation design to optimize learning. Int J Qual Health Care. 2018 Apr 20; 30(suppl_1):10-14. View Abstract
  17. Salzburg Global Seminar Session 565-'Better Health Care: how do we learn about improvement?' Int J Qual Health Care. 2018 Apr 20; 30(suppl_1):1-4. View Abstract
  18. Practical recommendations for the evaluation of improvement initiatives. Int J Qual Health Care. 2018 Apr 20; 30(suppl_1):29-36. View Abstract
  19. The Impact of the Medicaid Healthcare-Associated Condition Program on Mediastinitis Following Coronary Artery Bypass Graft. Infect Control Hosp Epidemiol. 2018 06; 39(6):694-700. View Abstract
  20. Highly Adoptable Improvement: A Practical Model and Toolkit to Address Adoptability and Sustainability of Quality Improvement Initiatives. Jt Comm J Qual Patient Saf. 2018 03; 44(3):155-163. View Abstract
  21. Are quality improvement collaboratives effective? A systematic review. BMJ Qual Saf. 2018 03; 27(3):226-240. View Abstract
  22. A Way Forward for Bipartisan Health Reform? Democrat and Republican State Legislator Priorities for the Goals of Health Policy. Am J Public Health. 2017 10; 107(10):1601-1603. View Abstract
  23. How to attribute causality in quality improvement: lessons from epidemiology. BMJ Qual Saf. 2017 11; 26(11):933-937. View Abstract
  24. Randomized Trial of Reducing Ambulatory Malpractice and Safety Risk: Results of the Massachusetts PROMISES Project. Med Care. 2017 08; 55(8):797-805. View Abstract
  25. Erratum to: Does a quality improvement campaign accelerate take-up of new evidence? A ten-state cluster-randomized controlled trial of the IHI's Project JOINTS. Implement Sci. 2017 05 10; 12(1):59. View Abstract
  26. Does a quality improvement campaign accelerate take-up of new evidence? A ten-state cluster-randomized controlled trial of the IHI's Project JOINTS. Implement Sci. 2017 04 17; 12(1):51. View Abstract
  27. Contribution of real-time PCR to Plasmodium species identification and to clinical decisions: a nationwide study in a non-endemic setting. Eur J Clin Microbiol Infect Dis. 2017 Apr; 36(4):671-675. View Abstract
  28. A Pediatric Approach to Ventilator-Associated Events Surveillance. Infect Control Hosp Epidemiol. 2017 03; 38(3):327-333. View Abstract
  29. Claims-Based Diagnostic Patterns of Patients Evaluated for Lyme Disease and Given Extended Antibiotic Therapy. Vector Borne Zoonotic Dis. 2017 02; 17(2):116-122. View Abstract
  30. Measuring Hospital-Wide Mortality-Pitfalls and Potential. J Healthc Qual. 2016 May-Jun; 38(3):187-94. View Abstract
  31. Parent and Teen Engagement in Pediatric Health Services Research Training. Acad Pediatr. 2016 07; 16(5):496-498. View Abstract
  32. The evolution of healthcare quality measurement in the United States. J Intern Med. 2016 Feb; 279(2):154-9. View Abstract
  33. Using Nation-Wide Health Insurance Claims Data to Augment Lyme Disease Surveillance. Vector Borne Zoonotic Dis. 2015 Oct; 15(10):591-6. View Abstract
  34. Incidence and Patterns of Extended-Course Antibiotic Therapy in Patients Evaluated for Lyme Disease. Clin Infect Dis. 2015 Nov 15; 61(10):1536-42. View Abstract
  35. Choosing Wisely in Newborn Medicine: Five Opportunities to Increase Value. Pediatrics. 2015 Aug; 136(2):e482-9. View Abstract
  36. Impact of the Centers for Medicare and Medicaid Services Hospital-Acquired Conditions Policy on Billing Rates for 2 Targeted Healthcare-Associated Infections. Infect Control Hosp Epidemiol. 2015 Aug; 36(8):871-7. View Abstract
  37. Staphylococcus epidermidis Bacteremia Induces Brain Injury in Neonatal Mice via Toll-like Receptor 2-Dependent and -Independent Pathways. J Infect Dis. 2015 Nov 01; 212(9):1480-90. View Abstract
  38. Teamwork methods for accountable care: relational coordination and TeamSTEPPS®. Health Care Manage Rev. 2015 Apr-Jun; 40(2):116-25. View Abstract
  39. Impact of Medicare's Hospital-Acquired Condition policy on infections in safety net and non-safety net hospitals. Infect Control Hosp Epidemiol. 2015 Jun; 36(6):649-55. View Abstract
  40. Response to: 'Working smarter, not harder' by Professor Iedema. BMJ Qual Saf. 2015 Apr; 24(4):289-90. View Abstract
  41. Evaluating ambulatory practice safety: the PROMISES project administrators and practice staff surveys. Med Care. 2015 Feb; 53(2):141-52. View Abstract
  42. A 'work smarter, not harder' approach to improving healthcare quality. BMJ Qual Saf. 2015 Feb; 24(2):100-2. View Abstract
  43. Health care-associated infections among critically ill children in the US, 2007-2012. Pediatrics. 2014 Oct; 134(4):705-12. View Abstract
  44. Approaches for preventing healthcare-associated infections: go long or go wide? Infect Control Hosp Epidemiol. 2014 Sep; 35 Suppl 2:S10-4. View Abstract
  45. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014 Sep; 35 Suppl 2:S21-31. View Abstract
  46. Coping with college and inflammatory bowel disease: implications for clinical guidance and support. Inflamm Bowel Dis. 2014 Sep; 20(9):1618-27. View Abstract
  47. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014 Aug; 35(8):967-77. View Abstract
  48. A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates. Am J Infect Control. 2014 Aug; 42(8):820-8. View Abstract
  49. Approaches for preventing healthcare-associated infections: go long or go wide? Infect Control Hosp Epidemiol. 2014 Jul; 35(7):797-801. View Abstract
  50. Did a quality improvement collaborative make stroke care better? A cluster randomized trial. Implement Sci. 2014 Apr 01; 9(1):40. View Abstract
  51. Impact of Medicare's payment policy on mediastinitis following coronary artery bypass graft surgery in US hospitals. Infect Control Hosp Epidemiol. 2014 Feb; 35(2):144-51. View Abstract
  52. Developing a pathway for high-value, patient-centered total joint arthroplasty. Clin Orthop Relat Res. 2014 May; 472(5):1619-35. View Abstract
  53. Recommendations for evaluation of health care improvement initiatives. Acad Pediatr. 2013 Nov-Dec; 13(6 Suppl):S23-30. View Abstract
  54. Hospital readmission and parent perceptions of their child's hospital discharge. Int J Qual Health Care. 2013 Oct; 25(5):573-81. View Abstract
  55. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):444-50. View Abstract
  56. Rethinking infection prevention research. Lancet. 2013 Mar 30; 381(9872):1078-9. View Abstract
  57. Preventing lethal hospital outbreaks of antibiotic-resistant bacteria. N Engl J Med. 2012 Dec 06; 367(23):2168-70. View Abstract
  58. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med. 2012 Oct 11; 367(15):1428-37. View Abstract
  59. A neonatal model of intravenous Staphylococcus epidermidis infection in mice <24 h old enables characterization of early innate immune responses. PLoS One. 2012; 7(9):e43897. View Abstract
  60. Deciphering harm measurement. JAMA. 2012 May 23; 307(20):2155-6. View Abstract
  61. Perceived impact of the Medicare policy to adjust payment for health care-associated infections. Am J Infect Control. 2012 May; 40(4):314-9. View Abstract
  62. Evaluation of organizational culture among different levels of healthcare staff participating in the Institute for Healthcare Improvement's 100,000 Lives Campaign. Infect Control Hosp Epidemiol. 2012 Feb; 33(2):135-43. View Abstract
  63. Impact of the ventilator bundle on ventilator-associated pneumonia in intensive care unit. Int J Qual Health Care. 2011 Oct; 23(5):538-44. View Abstract
  64. Health information management and perceptions of the quality of care for children with tracheotomy: a qualitative study. BMC Health Serv Res. 2011 May 23; 11:117. View Abstract
  65. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011 Apr 14; 364(15):1407-18. View Abstract
  66. Society's failure to protect a precious resource: antibiotics. Lancet. 2011 Jul 23; 378(9788):369-71. View Abstract
  67. Ten tips for incorporating scientific quality improvement into everyday work. BMJ Qual Saf. 2011 Apr; 20 Suppl 1:i69-72. View Abstract
  68. The promise of comparative effectiveness research. JAMA. 2011 Jan 26; 305(4):400-1. View Abstract
  69. Meaningful disparities reduction through research and translation programs. JAMA. 2011 Jan 26; 305(4):404-5. View Abstract
  70. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One. 2011 Jan 18; 6(1):e15452. View Abstract
  71. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med. 2010 Nov 25; 363(22):2124-34. View Abstract
  72. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest. 2010 Sep; 120(9):3220-33. View Abstract
  73. Performance characteristics of a methodology to quantify adverse events over time in hospitalized patients. Health Serv Res. 2011 Apr; 46(2):654-78. View Abstract
  74. Medication errors in paediatric outpatients. Qual Saf Health Care. 2010 Dec; 19(6):e30. View Abstract
  75. Reducing Clostridium difficile infection in acute care by using an improvement collaborative. BMJ. 2010 Jul 21; 341:c3359. View Abstract
  76. Patient characteristics associated with in-hospital mortality in children following tracheotomy. Arch Dis Child. 2010 Sep; 95(9):703-10. View Abstract
  77. Use of population health data to refine diagnostic decision-making for pertussis. J Am Med Inform Assoc. 2010 Jan-Feb; 17(1):85-90. View Abstract
  78. Patient safety attitudes of paediatric trainee physicians. Qual Saf Health Care. 2009 Dec; 18(6):462-6. View Abstract
  79. Is there a relationship between high-quality performance in major teaching hospitals and residents' knowledge of quality and patient safety? Acad Med. 2009 Nov; 84(11):1510-5. View Abstract
  80. Agitation during procedural sedation and analgesia in children. Clin Pediatr (Phila). 2010 Jan; 49(1):35-42. View Abstract
  81. A matter of time. JAMA. 2009 Aug 26; 302(8):894-5. View Abstract
  82. Predictors of clinical outcomes and hospital resource use of children after tracheotomy. Pediatrics. 2009 Aug; 124(2):563-72. View Abstract
  83. Parent-driven technology for decision support in pediatric emergency care. Jt Comm J Qual Patient Saf. 2009 Jun; 35(6):307-15. View Abstract
  84. Health care-associated infection reporting: the need for ongoing reliability and validity assessment. Am J Infect Control. 2009 Oct; 37(8):615-8. View Abstract
  85. Impact of enhanced infection control at 2 neonatal intensive care units in the Philippines. Clin Infect Dis. 2009 Jan 01; 48(1):13-21. View Abstract
  86. Controlled evaluation of Bactec Peds Plus/F and Bactec lytic/10 anaerobic/F media for isolation of Salmonella enterica serovars typhi and paratyphi A from blood. J Clin Microbiol. 2009 Jan; 47(1):245-6. View Abstract
  87. The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care. 2008 Oct; 17 Suppl 1:i13-32. View Abstract
  88. Impact of a patient-centered technology on medication errors during pediatric emergency care. Ambul Pediatr. 2008 Sep-Oct; 8(5):329-35. View Abstract
  89. Unit-based clinical pharmacists' prevention of serious medication errors in pediatric inpatients. Am J Health Syst Pharm. 2008 Jul 01; 65(13):1254-60. View Abstract
  90. Reducing absenteeism from gastrointestinal and respiratory illness in elementary school students: a randomized, controlled trial of an infection-control intervention. Pediatrics. 2008 Jun; 121(6):e1555-62. View Abstract
  91. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol. 2008 May; 43(5):463-71. View Abstract
  92. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics. 2008 Feb; 121(2):229-34. View Abstract
  93. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 2008 Jan; 121(1):e15-23. View Abstract
  94. Risk factors in preventable adverse drug events in pediatric outpatients. J Pediatr. 2008 Feb; 152(2):225-31. View Abstract
  95. Quality of health care for children: role of health and chronic illness in inpatient care experiences. Arch Pediatr Adolesc Med. 2007 Sep; 161(9):828-34. View Abstract
  96. Adverse drug events in pediatric outpatients. Ambul Pediatr. 2007 Sep-Oct; 7(5):383-9. View Abstract
  97. Impact of a hospitalist system on length of stay and cost for children with common conditions. Pediatrics. 2007 Aug; 120(2):267-74. View Abstract
  98. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2007 Jul; 75(7):3406-13. View Abstract
  99. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci U S A. 2007 May 01; 104(18):7528-33. View Abstract
  100. Healthcare-associated infection and antimicrobial resistance: moving beyond description to prevention. Infect Control Hosp Epidemiol. 2007 Mar; 28(3):261-4. View Abstract
  101. Prospective surveillance for surgical site infection in St. Petersburg, Russian Federation. Infect Control Hosp Epidemiol. 2007 Mar; 28(3):319-25. View Abstract
  102. Design and methodology of the Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR-ICU) trial. Infect Control Hosp Epidemiol. 2007 Feb; 28(2):245-6; author reply 246-8. View Abstract
  103. Hospital volumes for common pediatric specialty operations. Arch Pediatr Adolesc Med. 2007 Jan; 161(1):38-43. View Abstract
  104. The association of television and video viewing with fast food intake by preschool-age children. Obesity (Silver Spring). 2006 Nov; 14(11):2034-41. View Abstract
  105. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics. 2006 Oct; 118(4):1332-40. View Abstract
  106. Incorporating vaccine-preventable disease surveillance into the National Health Information Network: leveraging children's hospitals. Pediatrics. 2006 Oct; 118(4):1431-8. View Abstract
  107. System failure versus personal accountability--the case for clean hands. N Engl J Med. 2006 Jul 13; 355(2):121-3. View Abstract
  108. Microstream capnography improves patient monitoring during moderate sedation: a randomized, controlled trial. Pediatrics. 2006 Jun; 117(6):e1170-8. View Abstract
  109. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun. 2006 May; 74(5):2742-50. View Abstract
  110. Impact of patient-centered decision support on quality of asthma care in the emergency department. Pediatrics. 2006 Jan; 117(1):e33-42. View Abstract
  111. Patient misidentification in the neonatal intensive care unit: quantification of risk. Pediatrics. 2006 Jan; 117(1):e43-7. View Abstract
  112. An antibiotic order form intervention does not improve or reduce vancomycin use. Pediatr Infect Dis J. 2005 Dec; 24(12):1053-8. View Abstract
  113. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med. 2006 Feb 15; 173(4):421-5. View Abstract
  114. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine. J Infect Dis. 2005 Dec 01; 192(11):2012-9. View Abstract
  115. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2005 Oct; 73(10):6752-62. View Abstract
  116. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun. 2005 Oct; 73(10):6868-76. View Abstract
  117. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005 Sep; 116(3):e408-13. View Abstract
  118. A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics. 2005 Sep; 116(3):587-94. View Abstract
  119. Preventable adverse events in infants hospitalized with bronchiolitis. Pediatrics. 2005 Sep; 116(3):603-8. View Abstract
  120. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J. 2005 Sep; 24(9):766-73. View Abstract
  121. Real time patient safety audits: improving safety every day. Qual Saf Health Care. 2005 Aug; 14(4):284-9. View Abstract
  122. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2005 Jun; 49(6):2467-73. View Abstract
  123. Watchful waiting for acute otitis media: are parents and physicians ready? Pediatrics. 2005 Jun; 115(6):1466-73. View Abstract
  124. Identification of central venous catheter-related infections in infants and children. Pediatr Crit Care Med. 2005 May; 6(3 Suppl):S19-24. View Abstract
  125. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections. Clin Infect Dis. 2005 Jun 01; 40(11):1657-64. View Abstract
  126. Illness transmission in the home: a possible role for alcohol-based hand gels. Pediatrics. 2005 Apr; 115(4):852-60. View Abstract
  127. Medical errors detected and corrected by a pediatric infectious diseases consultation service. Infect Control Hosp Epidemiol. 2005 Apr; 26(4):417-20. View Abstract
  128. Hospital-acquired neonatal infections in developing countries. Lancet. 2005 Mar 26-Apr 1; 365(9465):1175-88. View Abstract
  129. Parents as partners in obtaining the medication history. J Am Med Inform Assoc. 2005 May-Jun; 12(3):299-305. View Abstract
  130. Evaluating vancomycin use at a pediatric hospital: new approaches and insights. Infect Control Hosp Epidemiol. 2005 Jan; 26(1):47-55. View Abstract
  131. Controlling meticillin-resistant Staphylococcus aureus, aka "Superbug". Lancet. 2005 Jan 22-28; 365(9456):273-5. View Abstract
  132. Feasibility of leveraging electronic data from pediatric hospitals for national surveillance: a survey of chief information officers. AMIA Annu Symp Proc. 2005; 954. View Abstract
  133. An outbreak of Pseudomonas aeruginosa pneumonia and bloodstream infection associated with intermittent otitis externa in a healthcare worker. Infect Control Hosp Epidemiol. 2004 Dec; 25(12):1083-9. View Abstract
  134. Medication errors in the neonatal intensive care unit: special patients, unique issues. Arch Dis Child Fetal Neonatal Ed. 2004 Nov; 89(6):F472-3. View Abstract
  135. The asthma kiosk: a patient-centered technology for collaborative decision support in the emergency department. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):458-67. View Abstract
  136. Voluntary anonymous reporting of medical errors for neonatal intensive care. Pediatrics. 2004 Jun; 113(6):1609-18. View Abstract
  137. Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis. 2004 May 15; 38(10):1383-90. View Abstract
  138. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol. 2004 Apr; 186(8):2449-56. View Abstract
  139. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine. 2004 Feb 17; 22(7):872-9. View Abstract
  140. Administrative databases provide inaccurate data for surveillance of long-term central venous catheter-associated infections. Infect Control Hosp Epidemiol. 2003 Dec; 24(12):946-9. View Abstract
  141. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003 Oct; 112(4):862-9. View Abstract
  142. Notifying emergency department patients of negative test results: pitfalls of passive communication. Pediatr Emerg Care. 2003 Aug; 19(4):226-30. View Abstract
  143. A clinical practice guideline for treatment of septic arthritis in children: efficacy in improving process of care and effect on outcome of septic arthritis of the hip. J Bone Joint Surg Am. 2003 Jun; 85(6):994-9. View Abstract
  144. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003 Apr; 111(4 Pt 1):722-9. View Abstract
  145. Evaluation and development of potentially better practices to prevent neonatal nosocomial bacteremia. Pediatrics. 2003 Apr; 111(4 Pt 2):e504-18. View Abstract
  146. Use of an alcohol-based hand rub and quality improvement interventions to improve hand hygiene in a Russian neonatal intensive care unit. Infect Control Hosp Epidemiol. 2003 Mar; 24(3):172-9. View Abstract
  147. Misconceptions about colds and predictors of health service utilization. Pediatrics. 2003 Feb; 111(2):231-6. View Abstract
  148. Senior resident autonomy in a pediatric hospitalist system. Arch Pediatr Adolesc Med. 2003 Feb; 157(2):206-7. View Abstract
  149. Binary cumulative sums and moving averages in nosocomial infection cluster detection. Emerg Infect Dis. 2002 Dec; 8(12):1426-32. View Abstract
  150. Impact of a health maintenance organization hospitalist system in academic pediatrics. Pediatrics. 2002 Oct; 110(4):720-8. View Abstract
  151. Time to tackle the tough issues in patient safety. Pediatrics. 2002 Oct; 110(4):823-6. View Abstract
  152. Effect of a pediatric hospitalist system on housestaff education and experience. Arch Pediatr Adolesc Med. 2002 Sep; 156(9):877-83. View Abstract
  153. Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr Infect Dis J. 2002 Aug; 21(8):715-23. View Abstract
  154. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun. 2002 Aug; 70(8):4433-40. View Abstract
  155. Blood-borne pathogens and nosocomial infections. J Allergy Clin Immunol. 2002 Aug; 110(2 Suppl):S21-6. View Abstract
  156. Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance. Pediatr Infect Dis J. 2002 Jun; 21(6):489-95. View Abstract
  157. Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in graft-derived neutrophils. Transplantation. 2002 May 15; 73(9):1522-6. View Abstract
  158. Pediatric hospitalists: what do we know, and where do we go from here? Ambul Pediatr. 2001 Nov-Dec; 1(6):340-5. View Abstract
  159. Computerized pharmacy databases as source of data on antimicrobial prescriptions in children's hospitals. Am J Health Syst Pharm. 2001 Nov 01; 58(21):2069-71. View Abstract
  160. Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis. 2001 Nov; 1(4):251-61. View Abstract
  161. Reducing infections among women undergoing cesarean section in Colombia by means of continuous quality improvement methods. Arch Intern Med. 2001 Oct 22; 161(19):2357-65. View Abstract
  162. Compliance with hand hygiene practice in pediatric intensive care. Pediatr Crit Care Med. 2001 Oct; 2(4):311-4. View Abstract
  163. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001 Jun; 107(6):1431-6. View Abstract
  164. An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. Int J Gynaecol Obstet. 2001 May; 73(2):141-5. View Abstract
  165. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001 Apr 25; 285(16):2114-20. View Abstract
  166. Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions. Emerg Infect Dis. 2001 Mar-Apr; 7(2):249-53. View Abstract
  167. Reality check: should we use vancomycin for the prophylaxis of intravascular catheter-associated infections? Infect Control Hosp Epidemiol. 2001 Mar; 22(3):176-9. View Abstract
  168. Market forces and organizational evolution at freestanding children's hospitals in the United States. Ambul Pediatr. 2001 Mar-Apr; 1(2):117-21. View Abstract
  169. Transmission of viral respiratory infections in the home. Pediatr Infect Dis J. 2000 Oct; 19(10 Suppl):S97-102. View Abstract
  170. Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol. 2000 Sep 29; 83(1-2):37-44. View Abstract
  171. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo. Infect Immun. 2000 Sep; 68(9):5120-5. View Abstract
  172. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect Immun. 2000 Aug; 68(8):4631-6. View Abstract
  173. Reducing medical error through systems improvement: the management of febrile infants. Pediatrics. 2000 Jun; 105(6):1330-2. View Abstract
  174. Risk-adjusted infection rates in surgery: a model for outcome measurement in hospitals developing new quality improvement programmes. J Hosp Infect. 2000 Jan; 44(1):43-52. View Abstract
  175. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr Infect Dis J. 2000 Jan; 19(1):56-65. View Abstract
  176. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics. 1999 Dec; 104(6):1327-33. View Abstract
  177. Quality of care at a children's hospital: the parent's perspective. Arch Pediatr Adolesc Med. 1999 Nov; 153(11):1123-9. View Abstract
  178. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 1999 May 28; 284(5419):1523-7. View Abstract
  179. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr. 1999 Apr; 134(4):413-21. View Abstract
  180. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun. 1999 Mar; 67(3):1213-9. View Abstract
  181. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med. 1999; 50:223-36. View Abstract
  182. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun. 1998 Oct; 66(10):4711-20. View Abstract
  183. Declining severity adjusted mortality: evidence of improving neonatal intensive care. Pediatrics. 1998 Oct; 102(4 Pt 1):893-9. View Abstract
  184. Prevention of occupationally acquired infections among heath-care workers. Pediatr Rev. 1998 Jul; 19(7):219-30; quiz 231. View Abstract
  185. Hospital infection prevention and control: a model for improving the quality of hospital care in low- and middle-income countries. Infect Control Hosp Epidemiol. 1998 Feb; 19(2):125-35. View Abstract
  186. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J. 1998 Jan; 17(1):10-7. View Abstract
  187. Social disparities in the use of diagnostic tests for children with gastroenteritis. Int J Qual Health Care. 1997 Dec; 9(6):419-25. View Abstract
  188. Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis. 1997 Jan; 24 Suppl 1:S139-45. View Abstract
  189. Resistance movement: the antibiotic crisis in hospitals. Health Syst Rev. 1997 Jan-Feb; 30(1):20-4. View Abstract
  190. When normal flora turn nasty. Pediatr Infect Dis J. 1996 Oct; 15(10):845-7. View Abstract
  191. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA. 1996 Jan 17; 275(3):234-40. View Abstract
  192. The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation. 1995 Nov 01; 92(9):2715-22. View Abstract
  193. A clinical pathway for pelvic inflammatory disease for use on an inpatient service. Clin Perform Qual Health Care. 1995 Oct-Dec; 3(4):185-96. View Abstract
  194. Promoting collaboration between hospital epidemiology and QI. Interview by Steven Berman. Jt Comm J Qual Improv. 1995 Sep; 21(9):493-500. View Abstract
  195. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J. 1995 Jun; 14(6):510-6. View Abstract
  196. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. Pediatr Clin North Am. 1995 Jun; 42(3):703-16. View Abstract
  197. Neonatal herpes simplex virus infection presenting as fulminant liver failure. Pediatr Infect Dis J. 1995 Mar; 14(3):242-4. View Abstract
  198. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics. 1995 Mar; 95(3):389-94. View Abstract
  199. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics. 1995 Feb; 95(2):225-30. View Abstract
  200. Potentiation of Staphylococcus epidermidis catheter-related bacteremia by lipid infusions. J Infect Dis. 1995 Jan; 171(1):220-4. View Abstract
  201. CRIB and SNAP. Lancet. 1994 Jul 09; 344(8915):124-5. View Abstract
  202. Estimating neonatal mortality risk: an analysis of clinicians' judgments. Pediatrics. 1994 Jun; 93(6 Pt 1):945-50. View Abstract
  203. Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis. 1994 May; 169(5):1042-9. View Abstract
  204. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis. 1994 Mar; 169(3):526-31. View Abstract
  205. Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci. J Infect Dis. 1993 Nov; 168(5):1211-8. View Abstract
  206. The immunization status of children with spina bifida. Am J Dis Child. 1993 Aug; 147(8):849-53. View Abstract
  207. Computed tomography imaging in children with head trauma: utilization and appropriateness from a quality improvement perspective. Infect Control Hosp Epidemiol. 1993 Aug; 14(8):491-9. View Abstract
  208. Birth weight and illness severity: independent predictors of neonatal mortality. Pediatrics. 1993 May; 91(5):969-75. View Abstract
  209. Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev. 1993 Apr; 6(2):176-92. View Abstract
  210. Hospital-based continuous quality improvement: a realistic appraisal. Clin Perform Qual Health Care. 1993 Apr-Jun; 1(2):69-80. View Abstract
  211. Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics. 1993 Mar; 91(3):617-23. View Abstract
  212. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun. 1993 Feb; 61(2):551-8. View Abstract
  213. Vancomycin-resistant enterococcus faecium: headline news. Infect Control Hosp Epidemiol. 1992 Dec; 13(12):695-9. View Abstract
  214. Variability in reprocessing policies and procedures for flexible fiberoptic endoscopes in Massachusetts hospitals. Am J Infect Control. 1992 Dec; 20(6):283-90. View Abstract
  215. The articular manifestations of Paget's disease of bone. A case report. Clin Orthop Relat Res. 1992 Dec; (285):250-4. View Abstract
  216. Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics. 1992 Oct; 90(4):561-7. View Abstract
  217. Transmission of infectious diseases in children. Pediatr Rev. 1992 Aug; 13(8):283-93. View Abstract
  218. Hand-washing and nosocomial infections. N Engl J Med. 1992 Jul 09; 327(2):120-2. View Abstract
  219. A service chief model for general pediatric inpatient care and residency training. Pediatrics. 1992 Apr; 89(4 Pt 1):601-7. View Abstract
  220. Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am J Med. 1992 Mar; 92(3):257-61. View Abstract
  221. Rapid detection of group A streptococci: comparative performance by nurses and laboratory technologists in pediatric satellite laboratories using three test kits. J Clin Microbiol. 1992 Jan; 30(1):138-42. View Abstract
  222. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation. 1991 Dec; 84(6):2539-46. View Abstract
  223. Contemporary challenges for hospital epidemiology. Am J Med. 1991 Sep 16; 91(3B):8S-15S. View Abstract
  224. Adaptation of the Centers for Disease Control guidelines for the prevention of nosocomial infection in a pediatric intensive care unit in Jakarta, Indonesia. Am J Med. 1991 Sep 16; 91(3B):213S-220S. View Abstract
  225. Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials. Infect Immun. 1991 Sep; 59(9):3323-6. View Abstract
  226. The role of barrier precautions in infection control. J Hosp Infect. 1991 Jun; 18 Suppl A:515-23. View Abstract
  227. False resistance to imipenem with a microdilution susceptibility testing system. J Clin Microbiol. 1991 Apr; 29(4):827-9. View Abstract
  228. Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis. Antimicrob Agents Chemother. 1991 Feb; 35(2):272-6. View Abstract
  229. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990 Dec 27; 323(26):1814-8. View Abstract
  230. Birth weight and length of stay as determinants of nosocomial coagulase-negative staphylococcal bacteremia in neonatal intensive care unit populations: potential for confounding. Am J Epidemiol. 1990 Dec; 132(6):1130-40. View Abstract
  231. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med. 1990 Aug 02; 323(5):301-8. View Abstract
  232. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis. 1990 Aug; 162(2):435-41. View Abstract
  233. Coagulase-negative staphylococci: interplay of epidemiology and bench research. Am J Infect Control. 1990 Jun; 18(3):211-21. View Abstract
  234. Enzymatically labelled nucleic acid (NA) probe assays for detection of Campylobacter spp. in human faecal specimens and in culture. Mol Cell Probes. 1990 Apr; 4(2):133-42. View Abstract
  235. Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations. Am J Dis Child. 1990 Mar; 144(3):324-9. View Abstract
  236. Microbial challenge of a blood cell separator outside-seal bowl system. Transfusion. 1990 Feb; 30(2):146-9. View Abstract
  237. Current issues in central venous catheter infection. Annu Rev Med. 1990; 41:169-76. View Abstract
  238. Prevention and management of neonatal infections. Infect Dis Clin North Am. 1989 Dec; 3(4):779-813. View Abstract
  239. AIDS: understanding the pathogenesis of HIV infection. Infect Control Hosp Epidemiol. 1989 Jun; 10(6):248-52. View Abstract
  240. Heterologous protection against invasive Escherichia coli K1 disease in newborn rats by maternal immunization with purified mannose-sensitive pili. Infect Immun. 1989 May; 57(5):1568-72. View Abstract
  241. Nosocomial viral infections: recent developments and new strategies. Eur J Clin Microbiol Infect Dis. 1989 Jan; 8(1):75-81. View Abstract
  242. Methodologic issues in hospital epidemiology. IV. Risk ratios, confounding, effect modification, and the analysis of multiple variables. Rev Infect Dis. 1988 Nov-Dec; 10(6):1118-41. View Abstract
  243. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother. 1988 Oct; 32(10):1528-32. View Abstract
  244. Infection control in Latin America. Infect Control Hosp Epidemiol. 1988 Jul; 9(7):291-301. View Abstract
  245. Performance of a solid phase enzyme immunoassay for detection of group A streptococci in a pediatric office laboratory as refereed by a hospital laboratory. Pediatr Infect Dis J. 1988 Jun; 7(6):393-8. View Abstract
  246. Fifteen-year experience with bloodstream isolates of coagulase-negative staphylococci in neonatal intensive care. J Clin Microbiol. 1988 Apr; 26(4):713-8. View Abstract
  247. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr. 1988 Apr; 112(4):547-54. View Abstract
  248. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis. 1988 Apr; 157(4):713-22. View Abstract
  249. Group B streptococcal infections of the central nervous system in infants with myelomeningocele. Surg Neurol. 1988 Mar; 29(3):237-42. View Abstract
  250. Effect of preoperative shampoos on resident scalp flora. Todays OR Nurse. 1988 Mar; 10(3):15-21. View Abstract
  251. The bacterial flora of neonates in intensive care-monitoring and manipulation. J Hosp Infect. 1988 Feb; 11 Suppl A:340-51. View Abstract
  252. Effect of preoperative shampoos with chlorhexidine or iodophor on emergence of resident scalp flora in neurosurgery. Infect Control. 1988 Jan; 9(1):8-12. View Abstract
  253. Effect of preoperative shampoos with chlorhexidine or iodophor on emergence of resident scalp flora in neurosurgery. Infect Control Hosp Epidemiol. 1988 Jan; 9(1):8-12. View Abstract
  254. Impact of rapid antigen tests for group A streptococcal pharyngitis on physician use of antibiotics and throat cultures. Pediatr Infect Dis J. 1987 Dec; 6(12):1095-102. View Abstract
  255. Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic? JAMA. 1987 Nov 13; 258(18):2548-52. View Abstract
  256. Confounding and the analysis of multiple variables in hospital epidemiology. Infect Control. 1987 Nov; 8(11):465-73. View Abstract
  257. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med. 1987 Aug 06; 317(6):329-34. View Abstract
  258. Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media. Diagn Microbiol Infect Dis. 1986 Nov; 5(4):299-305. View Abstract
  259. Nosocomial infection control in the United States of America. J Hosp Infect. 1986 Sep; 8(2):116-28. View Abstract
  260. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr. 1986 May; 108(5 Pt 2):806-12. View Abstract
  261. Strategies for preventing neonatal group B streptococcal disease. Infect Control. 1986 Feb; 7(2 Suppl):137-9, 143. View Abstract
  262. Pharmacokinetics of high-dose azlocillin sodium in patients with cystic fibrosis. Clin Pharm. 1985 Nov-Dec; 4(6):664-9. View Abstract
  263. Risk of illness after exposure to a pediatric office. N Engl J Med. 1985 Aug 15; 313(7):425-8. View Abstract
  264. Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis. Rev Infect Dis. 1985 Jul-Aug; 7 Suppl 3:S482-9. View Abstract
  265. Comparison of a new, rapid enzyme-linked immunosorbent assay with latex particle agglutination for the detection of Haemophilus influenzae type b infections. J Clin Microbiol. 1985 May; 21(5):711-4. View Abstract
  266. Purification and characterization of Haemophilus influenzae pili, and their structural and serological relatedness to Escherichia coli P and mannose-sensitive pili. J Exp Med. 1985 Jan 01; 161(1):145-59. View Abstract
  267. Intravenous fluid contamination, Aegean-style. Infect Control. 1984 Oct; 5(10):469-70. View Abstract
  268. Pilus-mediated adherence of Escherichia coli K1 to human oral epithelial cells. Infect Immun. 1984 Jul; 45(1):299-301. View Abstract
  269. Empyema in children: clinical course and long-term follow-up. Pediatrics. 1984 May; 73(5):587-93. View Abstract
  270. Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b. Antimicrob Agents Chemother. 1983 Nov; 24(5):658-62. View Abstract
  271. The role of pili and capsule in the pathogenesis of neonatal infection with Escherichia coli K1. J Infect Dis. 1983 Sep; 148(3):395-405. View Abstract
  272. Rifampin alone and in combination with trimethoprim in chemoprophylaxis for infections due to Haemophilus influenzae type b. Rev Infect Dis. 1983 Jul-Aug; 5 Suppl 3:S549-55. View Abstract
  273. In vitro activity of penicillin and rifampin against group B streptococci. Rev Infect Dis. 1983 Jul-Aug; 5 Suppl 3:S586-92. View Abstract
  274. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis. J Antimicrob Chemother. 1983 May; 11 Suppl B:195-203. View Abstract
  275. Nosocomial infection and death in a neonatal intensive care unit. J Infect Dis. 1983 Apr; 147(4):635-41. View Abstract
  276. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus. Antimicrob Agents Chemother. 1983 Apr; 23(4):571-6. View Abstract
  277. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo. J Infect Dis. 1983 Mar; 147(3):559-67. View Abstract
  278. Comparison of virulence and colonizing capacity of Escherichia coli K1 and non-K1 strains in neonatal rats. Infect Immun. 1982 Aug; 37(2):830-2. View Abstract
  279. Moxalactam pharmacokinetics in children. Antimicrob Agents Chemother. 1982 Jul; 22(1):47-50. View Abstract
  280. Nosocomial infections in a neonatal intensive care unit. J Infect Dis. 1981 Nov; 144(5):449-59. View Abstract
  281. Improved antibiotic usage following introduction of a novel prescription system. JAMA. 1981 Oct 16; 246(16):1796-800. View Abstract
  282. Mucoid Escherichia coli in cystic fibrosis. N Engl J Med. 1981 Jun 11; 304(24):1445-9. View Abstract
  283. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b. J Pediatr. 1981 Mar; 98(3):485-91. View Abstract
  284. Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study. Am J Med. 1981 Mar; 70(3):702-6. View Abstract
  285. Horizontal nonparenteral spread of hepatitis B among children. Ann Intern Med. 1981 Mar; 94(3):346-9. View Abstract
  286. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother. 1981 Feb; 19(2):294-7. View Abstract
  287. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. J Clin Microbiol. 1980 Jun; 11(6):552-7. View Abstract
  288. Haemophilus influenzae type B meningitis: a contagious disease of children. Br Med J. 1980 Mar 29; 280(6218):899-901. View Abstract
  289. Airborne transmission of chickenpox in a hospital. N Engl J Med. 1980 Feb 21; 302(8):450-3. View Abstract
  290. Salmonella bacteremia in the first year of life. J Pediatr. 1980 Jan; 96(1):57-9. View Abstract
  291. Guidelines for infection control in intravenous therapy. Lamp. 1979 Mar; 36(2):4-6. View Abstract
  292. Effect of ampicillin and chloramphenicol alone and in combination on ampicillin-susceptible and -resistant Haemophilus influenzae type B. Antimicrob Agents Chemother. 1979 Mar; 15(3):415-9. View Abstract
  293. Evaluation of blood culture procedures in a pediatric hospital. J Clin Microbiol. 1979 Jan; 9(1):88-92. View Abstract
  294. The role of nationwide nosocomial infection surveillance in detecting epidemic bacteremia due to contaminated intravenous fluids. Am J Epidemiol. 1978 Sep; 108(3):207-13. View Abstract
  295. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr. 1978 Aug; 93(2):288-93. View Abstract
  296. Quantitative blood cultures in childhood bacteremia. J Pediatr. 1978 May; 92(5):778-80. View Abstract
  297. Unreliability of fever and leukocytosis in the diagnosis of infection after cardiac valve surgery. J Thorac Cardiovasc Surg. 1978 Jan; 75(1):87-90. View Abstract
  298. Correlation of netilmicin agar dilution and disk diffusion susceptibilities. Antimicrob Agents Chemother. 1977 Aug; 12(2):288-9. View Abstract
  299. Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg. 1977 Mar; 73(3):470-9. View Abstract
  300. False-positive blood cultures. Association with nonsterile blood collection tubes. JAMA. 1976 Nov 01; 236(18):2073-5. View Abstract
  301. Editorial: Nosocomial infection--a hazard of newborn intensive care. N Engl J Med. 1976 Jun 10; 294(24):1342-3. View Abstract
  302. An outbreak of Shigella sonnei gastroenteritis on Colorado River raft trips. Am J Epidemiol. 1974 Sep; 100(3):186-96. View Abstract
  303. Letter: Contamination of fluid for parenteral nutrition. N Engl J Med. 1974 Jun 20; 290(25):1437-8. View Abstract
  304. Infection control in total parenteral nutrition. JAMA. 1973 Mar 19; 223(12):1360-4. View Abstract
  305. Staphylococcal disease related to hospital nursery bathing practices. A nationwide epidemiologic investigation. Pediatrics. 1973 Feb; 51(2):418-29. View Abstract

Contact Donald A. Goldmann

Print Profile